E Fund Management Co., Ltd. Avid Bioservices, Inc. Transaction History

E Fund Management Co., Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$6.34 - $9.28 $86,496 - $126,607	-13,643 Reduced 54.93%	11,194 $79,000
Q1 2024 May 13, 2024	BUY	$5.86 - $8.79 $26,299 - $39,449	4,488 Added 22.06%	24,837 $166,000
Q4 2023 Feb 06, 2024	BUY	$4.64 - $9.56 $94,419 - $194,536	20,349 New	20,349 $132,000
Q2 2023 Aug 11, 2023	BUY	$12.96 - $20.93 $12,350 - $19,946	953 Added 9.49%	10,990 $154,000
Q1 2023 May 11, 2023	SELL	$13.48 - $18.79 $90,194 - $125,723	-6,691 Reduced 40.0%	10,037 $188,000
Q4 2022 Feb 14, 2023	BUY	$12.61 - $18.74 $59,884 - $88,996	4,749 Added 39.64%	16,728 $230,000
Q3 2022 Nov 14, 2022	SELL	$15.33 - $20.36 $30,889 - $41,025	-2,015 Reduced 14.4%	11,979 $229,000
Q2 2022 Aug 15, 2022	BUY	$11.63 - $21.55 $36,739 - $68,076	3,159 Added 29.16%	13,994 $214,000
Q1 2022 May 12, 2022	BUY	$16.63 - $27.73 $180,186 - $300,454	10,835 New	10,835 $221,000

184

67.8M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $756M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.